Skip to main content

Table 1 Baseline clinical and laboratory characteristics of study participants

From: Clinical implications of carotid artery intima media thickness assessment on cardiovascular risk stratification in hyperlipidemic Korean adults with diabetes: the ALTO study

  Men Women p-value
(n = 178) (n = 177)
Age (years) 55.9 ± 10.9 60.2 ± 10.2 <0.001
Body mass index (kg/m2) 25.5 ± 3.1 25.2 ± 4.0 0.468
Waist circumference (cm) 90.6 ± 7.0 86.3 ± 10.0 <0.001
Duration of diabetes (years) 7.5 ± 7.3 8.6 ± 7.3 0.143
Systolic blood pressure (mmHg) 128.7 ± 13.5 128.2 ± 14.2 0.726
Diastolic blood pressure (mmHg) 79.3 ± 9.6 78.2 ± 8.9 0.257
Smoking, (never/ex/current) 38/72/68 169/2/6 <0.001
Family history of CHD (%) 12 (6.7) 9 (5.1) 0.654
Menopause 139 (78.5)
Atrial fibrillation (%) 2 (1.1) 2 (1.1) 0.686
ACE inhibition (%) 61 (34.3) 70 (39.5) 0.323
Antiplatelet medication (%) 51 (28.7) 44 (24.9) 0.472
Statin use (%) 114 (64) 123 (69.5) 0.311
Total cholesterol (mg/dL) 160.9 ± 32.9 169.8 ± 34.3 0.013
Triglycerides (md/dL) 155.3 ± 116.9 138.1 ± 81.3 0.108
HDL-C (mg/dL) 49.3 ± 11.2 54.8 ± 12.8 <0.001
LDL-C (mg/dL) 85.7 ± 28.7 91.3 ± 28.0 0.061
ApoB (mg/dL) 71.3 ± 21.4 71.8 ± 20.3 0.813
ApoA1 (mg/dL) 130.0 ± 27.4 137.8 ± 2.8 0.006
Fasting blood glucose (mg/dL) 137.0 ± 41.9 135.3 ± 39.6 0.694
HbA1c (%) 7.4 ± 1.1 7.5 ± 1.2 0.449
hsCRP (mg/L)a 0.5 ± 0.9 0.5 ± 0.9 0.618
Albumin/creatinine ratioa 12.1 ± 26.7 12.1 ± 28.6 0.239b
  1. Values are mean ± SD; aMedian ± IQR; bThe variable was log transformed before statistical analysis
  2. ACE, angiostensin-converting enzyme; Apo, apolipoprotein; CHD, coronary heart disease; HbA1c, glycated hemoglobin; HDL-C, high density lipoprotein cholesterol; hsCRP, high-sensitivity C-reactive protein; IQR, interquartile range; LDL-C, low density lipoprotein cholesterol; SD, standard deviation